Application of Fragment-Based Drug Discovery against DNA GyraseB

被引：14

作者：

Chen, Guo-Ying ^{[1
]}

Ng, Fui Mee ^{[1
]}

Tan, Yih Wan ^{[1
]}

Poulsen, Anders ^{[1
]}

Seetoh, Weiguang ^{[1
]}

Lin, Grace ^{[1
]}

Kang, CongBao ^{[1
]}

Then, Siew Wen ^{[1
]}

Ahmad, Nur Huda ^{[1
]}

Wong, Ying Lei ^{[1
]}

Ng, Hui Qi ^{[1
]}

Chia, C. S. Brian ^{[1
]}

Lau, Qiu Ying ^{[1
]}

Hill, Jeffrey ^{[1
]}

Hung, Alvin W. ^{[1
]}

Keller, Thomas H. ^{[1
]}

机构：

[1] ASTAR, Ctr Expt Therapeut, Singapore 138667, Singapore

来源：

CHEMPLUSCHEM | 2015年 / 80卷 / 08期

关键词：

antibiotics; drug design; drug discovery; inhibitors; ligand effects; MYCOBACTERIUM-TUBERCULOSIS; ANTIBACTERIAL AGENTS; TOPOISOMERASE-IV; B PROTEIN; INHIBITORS; OPTIMIZATION; POTENT; HIT; RESISTANCE; DESIGN;

D O I：

10.1002/cplu.201500197

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Bacterial resistance to antibiotics remains a serious threat to global health. The gyraseB enzyme is a well-validated target for developing antibacterial drugs. Despite being an attractive target for antibiotic development, there are currently no gyraseB inhibitory drugs on the market. A fragment screen using 1,800compounds identified 14fragments that bind to Escherichia coli (E.coli) gyraseB. The detailed characterization of binding is described for all 14fragments. With the aid of X-ray crystallography, modifications on a low-affinity fragment (K-D=253M, IC50=634M) has led to the development of a new class of potent phenyl aminopyrazole inhibitors against E.coli gyraseB (IC50=160nM). The study presented here combines the use of a set of biophysical techniques including differential scanning fluorimetry, nuclear magnetic resonance, isothermal titration calorimetry, and X-ray crystallography to methodically identify, quantify, and optimize fragments into new chemical leads.

引用

页码：1250 / 1254

页数：5

共 50 条

[1] Fragment-based drug discovery
Erlanson, DA
McDowell, RS
O'Brien, T
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) : 3463 - 3482
[2] Fragment-based drug discovery
Wendy A. Warr
Journal of Computer-Aided Molecular Design, 2009, 23 : 453 - 458
[3] Fragment-based drug discovery
Warr, Wendy A.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2009, 23 (08) : 453 - 458
[4] Fragment-Based Drug Discovery
Norton, Raymond S.
AUSTRALIAN JOURNAL OF CHEMISTRY, 2013, 66 (12) : 1463 - 1464
[5] Application of Fragment-Based Drug Discovery to Versatile Targets
Li, Qingxin
FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[6] Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
Togre, Namdev S.
Vargas, Ana M.
Bhargavi, Gunapati
Mallakuntla, Mohan Krishna
Tiwari, Sangeeta
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
[7] Fragment-based drug discovery and its application to challenging drug targets
Price, Amanda J.
Howard, Steven
Cons, Benjamin D.
STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY, 2017, 61 (05): : 475 - 484
[8] Experiences in fragment-based drug discovery
Murray, Christopher W.
Verdonk, Marcel L.
Rees, David C.
TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 224 - 232
[9] The rise of fragment-based drug discovery
Murray, Christopher W.
Rees, David C.
NATURE CHEMISTRY, 2009, 1 (03) : 187 - 192
[10] Introduction to Fragment-Based Drug Discovery
Erlanson, Daniel A.
FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 1 - 32

← 1 2 3 4 5 →